Reports Archive   Year   
Date Title Pages Source Download
Sep-21 Key prescription trends in the US market   15 Nirmal Bang
Sep-21 Recovery in volumes, non-Covid drugs pushed up IPM growth to 18%   28 Anand Rathi
Sep-21 NLEM revision: limited impact on most companies   11 Emkay Research
Aug-21 Indian Pharma Industry to surpass USD 60 billion in two years   3 CARE Research
Aug-21 Q1 FY22 Pharma Results review   16 Anand Rathi
Aug-21 Growth normalised with fall in covid-19 cases   15 Prabhudas Lilladher
Jul-21 IPM growth broadly normalised in Jun'21   15 Prabhudas Lilladher
Jul-21 Rx for outperformance: Niche generics in US and chronic in India   123 Emkay Research
Jul-21 IPM growth moderates in Jun'21 as Covid-19 tailwind recedes   13 Emkay Research
Jul-21 IPM growth in June stabilises at 14%   28 Anand Rathi
Jun-21 Yet another Revlimid settlement   11 Emkay Research
Jun-21 IPM May: 2nd wave + low base drives growth   15 Prabhudas Lilladher
Jun-21 Covid induced demand pushes IPM growth to 47.8%   28 Anand Rathi
Jun-21 COVID-19 boost to IPM sustains in May'21 as well   26 Motilal Oswal
May-21 IPM growth rebounds on low base and second Covid wave   13 Emkay Research
May-21 Lower base, Covid-19 drugs push IPM growth to 51.5%   28 Anand Rathi
May-21 Notable prescription trends   8 Nirmal Bang
Apr-21 IPM growth accelerates to mid-teens in Mar'21   13 Emkay Research
Apr-21 Opportunities and challenges aplenty   10 Emkay Research
Apr-21 Sector Update Pharmaceutical   10 Edelweiss Securities
Apr-21 4QFY21 earnings to be under pressure   3 Nirmal Bang
Mar-21 Growth visibility remains strong   7 ICICI Securities
Mar-21 Healthcare Update: March 2021   3 CARE Research
Mar-21 Drugs & Pharma Update: March 2021   3 CARE Research
Feb-21 IPM growth decelerates in Jan'21   13 Emkay Research
Feb-21 India Pharma - Growth Trajectory Maintained   28 Anand Rathi
Jan-21 Ample catalysts to sustain luster   19 HDFC Securities
Jan-21 IPM recovery, ~16% exports growth hint another solid quarter   13 Ashika Stock Broking
Jan-21 Domestic revival, exports traction hint at normalcy convergence...   5 ICICI
Jan-21 Ample catalysts to sustain luster   19 HDFC Securities